2025 Aug 26;68(Suppl 1):S982
GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management
The longer or more frequently your blood sugar is elevated, the more time it has to cause cellular and tissue damage and promote insulin resistance, predisposing you to degenerative disease and accelerated aging
Cavallo I, Sivori F, Mastrofrancesco A, Abril E, Pontone M, Di Domenico EG
Its an unnecessary risk to use compounded versions of these medications